Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 423

Similar articles for PubMed (Select 17640156)

1.

Revisiting monoamine oxidase inhibitors.

Krishnan KR.

J Clin Psychiatry. 2007;68 Suppl 8:35-41. Review.

PMID:
17640156
2.

The use of monoamine oxidase inhibitors in primary care.

Culpepper L.

J Clin Psychiatry. 2012;73 Suppl 1:37-41. doi: 10.4088/JCP.11096su1c.06. Review.

PMID:
22951241
3.

The transdermal delivery system of monoamine oxidase inhibitors.

VanDenBerg CM.

J Clin Psychiatry. 2012;73 Suppl 1:25-30. doi: 10.4088/JCP.11096su1c.04. Review.

PMID:
22951239
4.

Transdermal selegiline: a novel MAOI formulation for depression.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2006 Jul;44(7):9-12. Review. No abstract available.

PMID:
17310829
5.

The role of monoamine oxidase inhibitors in depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012;73 Suppl 1:10-6. doi: 10.4088/JCP.11096su1c.02.

PMID:
22951237
6.
7.

Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.

Flockhart DA.

J Clin Psychiatry. 2012;73 Suppl 1:17-24. doi: 10.4088/JCP.11096su1c.03. Review.

PMID:
22951238
8.

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2012;73 Suppl 1:31-6. doi: 10.4088/JCP.11096su1c.05. Review.

PMID:
22951240
9.

Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.

Shulman KI, Fischer HD, Herrmann N, Huo CY, Anderson GM, Rochon PA.

J Clin Psychiatry. 2009 Dec;70(12):1681-6. doi: 10.4088/JCP.08m05041blu. Epub 2009 Oct 20.

PMID:
19852903
10.

MAOIs and depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012 Jul;73(7):e24. doi: 10.4088/JCP.11096tx4c.

PMID:
22901357
11.

Spontaneous hypertensive reactions with monoamine oxidase inhibitors.

Lavin MR, Mendelowitz A, Kronig MH.

Biol Psychiatry. 1993 Aug 1;34(3):146-51. Review.

PMID:
8399806
12.

Monoamine oxidase inhibitors: safety and efficacy issues.

Brown CS, Bryant SG.

Drug Intell Clin Pharm. 1988 Mar;22(3):232-5. Review.

PMID:
3284731
13.

Tyramine and new monoamine oxidase inhibitor drugs.

Simpson GM, de Leon J.

Br J Psychiatry Suppl. 1989 Oct;(6):32-7. Review.

PMID:
2695125
14.

MAOIs: issues in treatment adherence and rates of treatment failure.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2013 Jan;74(1):e02. doi: 10.4088/JCP.11096tx7c.

PMID:
23419230
15.

Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

Patkar AA, Pae CU, Masand PS.

CNS Spectr. 2006 May;11(5):363-75. Review.

PMID:
16641841
16.

Transdermal selegiline.

Patkar AA, Pae CU, Zarzar M.

Drugs Today (Barc). 2007 Jun;43(6):361-77. Review.

PMID:
17612708
17.
18.

Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.

Cooper AJ.

Br J Psychiatry Suppl. 1989 Oct;(6):38-45. Review.

PMID:
2695126
19.
20.

Translating the evidence on atypical depression into clinical practice.

Hyman Rapaport M.

J Clin Psychiatry. 2007;68 Suppl 3:31-6. Review.

PMID:
17348765
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk